Kevin Zbuk

2.1k total citations
36 papers, 1.3k citations indexed

About

Kevin Zbuk is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Kevin Zbuk has authored 36 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 11 papers in Molecular Biology and 10 papers in Cancer Research. Recurrent topics in Kevin Zbuk's work include Genetic factors in colorectal cancer (7 papers), PI3K/AKT/mTOR signaling in cancer (6 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Kevin Zbuk is often cited by papers focused on Genetic factors in colorectal cancer (7 papers), PI3K/AKT/mTOR signaling in cancer (6 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Kevin Zbuk collaborates with scholars based in Canada, United States and United Kingdom. Kevin Zbuk's co-authors include Charis Eng, Kristin Waite, Sonia S. Anand, John R. Goffin, Marcus G. Pezzolesi, Shanna Gustafson, Attila Patócs, Oren Levine, Raimond Wong and Ying Ni and has published in prestigious journals such as Journal of Clinical Oncology, Nature reviews. Cancer and The American Journal of Human Genetics.

In The Last Decade

Kevin Zbuk

34 papers receiving 1.2k citations

Peers

Countries citing papers authored by Kevin Zbuk

Since Specialization

Citations

This map shows the geographic impact of Kevin Zbuk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Zbuk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Zbuk more than expected).

Fields of papers citing papers by Kevin Zbuk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Zbuk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Zbuk. The network helps show where Kevin Zbuk may publish in the future.

Co-authorship network of co-authors of Kevin Zbuk

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Zbuk. A scholar is included among the top collaborators of Kevin Zbuk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Zbuk. Kevin Zbuk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pan-Canadian consensus recommendations for GIST management in high- and low-throughput centres across Canada 2024 ·Therapeutic Advances in Medical Oncology ·J. Robert Beecroft, Savtaj S. Brar, Xiaolan Feng, Trevor D. Hamilton, (unknown), Jan‐Willem Henning, P. David Josephy, Korosh Khalili, Yoo‐Joung Ko, (unknown), David Liu, (unknown), Jonathan Noujaim, Aaron Pollett, Abdulazeez Salawu, Ramy Saleh, Alannah Smrke, (unknown), Kevin Zbuk, Albiruni Abdul Razak	1
2	Regional Therapies for Colorectal Liver Metastases: Systematic Review and Clinical Practice Guideline 2020 ·Clinical Colorectal Cancer ·Paul J. Karanicolas, J. Robert Beecroft, Roxanne Cosby, Elizabeth David, (unknown), Erin Kennedy, Gonzalo Sapisochín, Rebecca Wong, Kevin Zbuk	13
3	Predictors of mammographic density among women with a strong family history of breast cancer 2019 ·BMC Cancer ·(unknown), Andrea Eisen, Rochelle Demsky, Kristina M. Blackmore, Julia A. Knight, Seema Panchal, Ophira Ginsburg, Kevin Zbuk, Martin J. Yaffe, Kelly Metcalfe, Steven A. Narod, Joanne Kotsopoulos	9
4	ATM whole gene deletion in an Italian family with hereditary pancreatic cancer: Challenges to cancer risk prediction associated with an 11q22.3 microdeletion 2019 ·Cancer Genetics ·Heleen H. Arts, (unknown), Daria Grafodatskaya, Barry Eng, (unknown), (unknown), (unknown), (unknown), (unknown), Kevin Zbuk, M. Elizabeth McCready	2
5	SDH-deficient renal cell carcinoma – clinical, pathologic and genetic correlates: a case report 2018 ·BMC Urology ·(unknown), Michael Bonert, Asghar Naqvi, Kevin Zbuk, Anil Kapoor	18
6	Serum osteoprotegerin levels and mammographic density among high-risk women 2018 ·Cancer Causes & Control ·(unknown), (unknown), Andrea Eisen, Rochelle Demsky, Kristina M. Blackmore, Julia A. Knight, Christine Elser, Ophira Ginsburg, Kevin Zbuk, Martin J. Yaffe, Steven A. Narod, Leonardo Salmena, Joanne Kotsopoulos	6
7	Role of the status of the mesorectal fascia in the selection of patients with rectal cancer for preoperative radiation therapy: a retrospective cohort study 2018 ·Canadian Journal of Surgery ·Marko Šimunović, (unknown), Kevin Zbuk, Raimond Wong, Angela Coates	4
8	Utility of the Edmonton Frail Scale in identifying frail elderly patients during treatment of colorectal cancer 2017 ·Journal of Gastrointestinal Oncology ·Brandon M. Meyers, Humaid O. Al‐Shamsi, (unknown), Radhika Yelamanchili, (unknown), Αλεξάνδρα Παπαϊωάννου, Gregory R. Pond, (unknown), Kevin Zbuk, Sukhbinder Dhesy‐Thind	23
9	Systemic Therapy in Incurable Gastroenteropancreatic Neuroendocrine Tumours: A Clinical Practice Guideline 2017 ·Current Oncology ·Simron Singh, (unknown), Timothy R. Asmis, (unknown), (unknown), Calvin Law, Rebecca Wong, Kevin Zbuk	5
10	Targeted metabolomics in colorectal cancer: a strategic approach using standardized laboratory tests of the blood and urine 2017 ·PubMed ·Katarzyna J. Jerzak, (unknown), (unknown), Peter A. Kavsak, Kelvin Chan, Sukhbinder Dhesy‐Thind, Kevin Zbuk	6
11	Double heterozygosity for germline mutations in BRCA1 and p53 in a woman with early onset breast cancer 2014 ·Breast Cancer Research and Treatment ·Katrina M. Bell, Nicole Hodgson, Michelle S. Levine, Bekim Sadiković, Kevin Zbuk	6
12	Prospective study of high-risk, BRCA1/2-mutation negative women: the ‘negative study’ 2014 ·BMC Cancer ·Joanne Kotsopoulos, Kelly Metcalfe, (unknown), (unknown), Ophira Ginsburg, Andrea Eisen, Rochelle Demsky, Mohammad R. Akbari, Kevin Zbuk, Steven A. Narod	12
13	Epidermal Growth Factor Receptor: Pathway, Therapies, and Pipeline 2013 ·Clinical Therapeutics ·John R. Goffin, Kevin Zbuk	70
14	Accelerated muscle and adipose tissue loss may predict survival in pancreatic cancer patients: the relationship with diabetes and anaemia 2012 ·British Journal Of Nutrition ·Katie M. Di Sebastiano, Lin Yang, Kevin Zbuk, Raimond Wong, (unknown), David Koff, Gerald Moran, Marina Mourtzakis	112
15	Germline Mutations and Variants in the Succinate Dehydrogenase Genes in Cowden and Cowden-like Syndromes 2008 ·The American Journal of Human Genetics ·Ying Ni, Kevin Zbuk, Tammy Sadler, Attila Patócs, Glenn P. Lobo, Emily Edelman, Petra Platzer, Mohammed S. Orloff, Kristin Waite, Charis Eng	145
16	Cowden Syndrome–Affected Patients with PTEN Promoter Mutations Demonstrate Abnormal Protein Translation 2007 ·The American Journal of Human Genetics ·Rosemary E. Teresi, Kevin Zbuk, Marcus G. Pezzolesi, Kristin Waite, Charis Eng	67
17	Severe TMD/AMKL with GATA1 mutation in a stillborn fetus with Down syndrome 2007 ·Nature Clinical Practice Oncology ·Brandie Heald, Joanne M. Hilden, Kevin Zbuk, Alice Norton, Paresh Vyas, Karl S. Theil, Charis Eng	19
18	Comparative genomic and functional analyses reveal a novel cis-acting PTEN regulatory element as a highly conserved functional E-box motif deleted in Cowden syndrome 2007 ·Human Molecular Genetics ·Marcus G. Pezzolesi, Kevin Zbuk, Kristin Waite, Charis Eng	47
19	Hamartomatous polyposis syndromes 2007 ·Nature Clinical Practice Gastroenterology &#38 Hepatology ·Kevin Zbuk, Charis Eng	155
20	Cancer phenomics: RET and PTEN as illustrative models 2006 ·Nature reviews. Cancer ·Kevin Zbuk, Charis Eng	172

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact